{"success":true,"data":{"pressRelease":{"id":"154594","rtpr_id":"nGNX5YLbKk-20260928","ticker":"POCI","exchange":"NASDAQ","all_tickers":["POCI"],"title":"Precision Optics Reports Fourth Quarter and Fiscal Year 2026 Financial Results","author":"Globe Newswire","published_at":"2026-09-28T20:30:00.481Z","article_body":"LITTLETON, Mass., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Precision Optics\nCorporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of\nadvanced optical instruments for the medical and defense/aerospace industries,\ntoday announced financial results for its fourth quarter and fiscal year ended\nJune 30, 2026.\n\nQ4 2026 Financial Highlights (3 Months Ended June 30, 2026)\n* Revenue was $8.8 million, a quarterly record, compared to $6.2 million in\nthe same quarter of the previous fiscal year, representing growth of\napproximately 42%, and compared to $8.7 million in the most recent sequential\nquarter.\n* Production revenue was $8.0 million, a quarterly record, compared to $5.1\nmillion in the same quarter of the previous fiscal year, representing growth\nof approximately 57%, and compared to $7.6 million in the most recent\nsequential quarter.\n* Gross margin was 25.3% compared to 13.0% in the same quarter of the previous\nfiscal year and compared to 23.6% in the most recent sequential quarter.\n* Net loss for the quarter was $(0.1) million, compared to a net loss of\n$(1.4) million in the same quarter of the previous fiscal year and a net loss\nof $(0.1) million in the most recent sequential quarter.\n* Adjusted EBITDA was $0.4 million for the quarter compared to $(0.9) million\nin the same quarter of the previous fiscal year and $0.3 million in the most\nrecent sequential quarter.\nFY 2026 Financial Highlights (Year Ended June 30, 2026)\n* Revenue was $31.5 million, a fiscal year record, compared to $19.1 million\nin the previous fiscal year, representing growth of approximately 65%.\n* Production revenue doubled to $28.1 million compared to $14.2 million in the\nprevious fiscal year.\n* Gross margin was 17.2% compared to 17.8% in the previous fiscal year.\n* Net loss for the fiscal year declined to $(3.6) million, or $(0.43) per\nshare, from $(5.8) million, or $(0.85) per share, in the previous fiscal year.\n* Adjusted EBITDA was $(2.1) million for the fiscal year compared to $(3.7)\nmillion in the previous fiscal year, an improvement of approximately $1.6\nmillion.\n* Cash and cash equivalents were $9.8 million at June 30, 2026, compared to\n$1.8 million at June 30, 2025.\nRecent Additional Highlights\n* Achieved record quarterly revenue from the Company’s existing top-tier\naerospace customer and continued strong production of its single-use\ncystoscopy surgery system.\n* Continued ramping production under the previously announced $3.5 million\nfollow-on order for the single-use ophthalmic program.\n* Received a $1.3 million follow-on production order from a large defense\ncompany.\n* Recently announced an initial engineering order from a U.S. space technology\ncompany.\n* Continued strengthening the Company’s leadership team with the appointment\nof Peter Thier as Senior Vice President of Sales and Marketing.\nFY 2027 Financial Guidance (Year Ending June 30, 2027)\n* The Company expects fiscal year 2027 revenue to be in the range of $30\nmillion to $33 million, similar to fiscal year 2026. The outlook reflects a\npause in demand from the Company’s existing satellite customer with growth\nin single-use medical device programs, renewed defense production, additional\nprograms transitioning into production and new engineering engagements\nexpecting to partly offset this reduction. The Company expects a stronger\nsecond half of the year as orders are expected to resume from the existing\nsatellite customer.\n* The Company expects fiscal year 2027 Adjusted EBITDA to be in a range of\n$(1.2) million to $(1.7) million.\n“Fiscal 2026 was a year of transformation for Precision Optics, and our\nfourth-quarter results demonstrate the progress we have made. We delivered\nrecord quarterly revenue, and a second consecutive quarter of positive\nAdjusted EBITDA, closing a year in which revenue grew 65%,” said Joe Forkey,\nCEO of Precision Optics. “Our fiscal 2027 revenue guidance is significantly\nimpacted by the temporary pause in production with our existing satellite\ncustomer. As that customer resumes orders and we execute on growing existing\nand new customers, we anticipate returning to record quarterly revenue levels\nin the second half of the fiscal year. We believe there is a significant\nmarket opportunity, and we will continue to invest in capabilities, capacity\nand market penetration.”\n\n“Rebuilding our product development pipeline is a priority led by our new\nSVP of Sales and Marketing. We received an initial engineering order from a\nsecond satellite customer. Although it is still early, we see the potential to\nbuild another meaningful, long-term production relationship.”\n\nThe following table summarizes the fourth quarter and fiscal year results for\nthe periods ended June 30, 2026 and 2025. Fourth-quarter results are\nunaudited.\n\n Three Months Ended June 30 2026 Three Months Ended June 30 2025 Year Ended June 30 2026 Year Ended June 30 2025 \n Revenues $ 8,774,474 $ 6,181,342 $ 31,531,765 $ 19,091,269 \n Cost of goods sold 6,550,806 5,382,155 26,100,545 15,686,836 \n Gross profit 2,223,668 799,187 5,431,220 3,404,433 \n Total operating expenses 2,330,228 2,155,229 8,939,828 8,955,724 \n Operating income (loss) (106,560 ) (1,356,042 ) (3,508,608 ) (5,551,291 ) \n Interest income (expense), net (971) (44,577) (116,325) (227,019) \n Income (loss) before income taxes (107,531) (1,400,619) (3,624,933) (5,778,310) \n Income tax expense (benefit) (3,744) 1,936 4,958 1,936 \n Net Loss $ (103,787 ) $ (1,402,555 ) $ (3,629,891 ) $ (5,780,246 ) \n Earnings (loss) per share, basic $(0.01) $(0.18) $(0.43) $(0.85) \n Earnings (loss) per share, diluted $(0.01) $(0.18) $(0.43) $(0.85) \n Weighted average shares, basic 10,943,843 7,690,084 8,530,599 6,790,466 \n Weighted average shares, diluted 10,943,843 7,690,084 8,530,599 6,790,466 \n\nConference Call Details\n\nDate and Time: Monday, September 28, 2026, at 5:00 p.m. ET.\n\nCall-in Information: Interested parties can access the conference call by\ndialing (844) 735-3662 or (412) 317-5705.\n\nLive Webcast Information: Interested parties can access the conference call\nvia a live webcast, which will be available at\nhttps://app.webinar.net/0E4e7l07PjV.\n\nReplay: A teleconference replay of the call will be available for seven days\nat (855) 669-9658 or (412) 317-0088, replay access code 7128172. A webcast\nreplay will be available at https://app.webinar.net/0E4e7l07PjV.\n\nAbout Precision Optics Corporation\n\nFounded in 1982, Precision Optics is a vertically integrated optics company\nfocused on leveraging its proprietary micro-optics, multi-channel and\nultra-high precision imaging and digital imaging technologies across the\nmedical device, defense/aerospace and satellite communications markets.\nThrough its Systems Manufacturing, Engineering, Ross Optical and Micro-Optics\nLab operations, the Company provides services from new product concept and\ndesign through volume production. Its in-house optical, mechanical, electrical\nand systems engineering, prototyping, regulatory support, fabrication,\nassembly and manufacturing capabilities enable it to develop next-generation\nsolutions for demanding customer requirements. In medical devices, Precision\nOptics supports minimally invasive and robotic surgery with micro-endoscopes,\nsingle-use and reusable endoscopes, digital imaging and related optical\nassemblies. In defense/aerospace and satellite communications, the Company\napplies its micro-optics and opto-mechanical expertise to applications\nrequiring high quality and optimized size, weight and power. Ross Optical\ncomplements these capabilities through global sourcing, inspection and\nproduction of custom and catalog optics. For more information, please visit\nwww.poci.com.\n\nNon-GAAP Financial Measures\n\nPrecision Optics has provided in this press release financial information that\nhas not been prepared in accordance with accounting principles generally\naccepted in the United States of America (“non-GAAP”). The non-GAAP\nfinancial measure is Adjusted EBITDA (earnings before interest, taxes,\ndepreciation and amortization). In addition to these items, Adjusted EBITDA\nexcludes from Net Income (Loss) the effect of stock-based compensation,\ninterest expense and interest income, depreciation and amortization and income\ntaxes..\n\nThis non-GAAP financial measure assists Precision Optics management in\ncomparing its operating performance over time because certain items may\nobscure the underlying business trends and make comparisons of long-term\nperformance difficult, as they are of a nature and/or size that occur with\ninconsistent frequency or relate to discrete acquisition or restructuring\nplans that are fundamentally different from the ongoing productivity of the\nCompany. Precision Optics management also believes that presenting this\nmeasure allows investors to view its performance using the same measures that\nthe Company uses in evaluating its financial and business performance and\ntrends.\n\nNon-GAAP financial measures should not be considered in isolation from, or as\na substitute for, financial information calculated in accordance with GAAP.\nInvestors are encouraged to review the reconciliation of non-GAAP measures to\ntheir most directly comparable GAAP financial measures. A reconciliation of\nthe non-GAAP financial measure presented above to GAAP results has been\nprovided in the financial tables included with this press release.\n\nPrecision Optics is unable to provide a reconciliation of forward-looking\nAdjusted EBITDA guidance to net income (loss), the most directly comparable\nGAAP financial measure, without unreasonable efforts because of the inherent\ndifficulty in forecasting and quantifying certain amounts that are necessary\nfor such reconciliation, including stock-based compensation expense, which may\nvary significantly based on stock price and other factors outside the\nCompany’s control. The unavailable information could have a significant\neffect on the Company’s GAAP financial results.\n\nAbout Forward-Looking Statements\n\nThis press release contains forward-looking statements within the meaning of\nU.S. federal securities laws including statements concerning our fiscal year\n2027 revenue and Adjusted EBITDA guidance, our expectations regarding customer\ndemand and order resumption, and our anticipated return to record revenue\nlevels. Any statements contained herein that are not statements of historical\nfact may be deemed to be forward-looking statements. In addition, any\nstatements that refer to projections, forecasts, or other characterizations of\nfuture events or circumstances, including any underlying assumptions, are\nforward-looking statements. The words \"anticipate,\" \"believe,\" \"continue,\"\n\"could,\" \"estimate,\" \"expect,\" \"intends,\" \"may,\" \"might,\" \"plan,\" \"possible,\"\n\"potential,\" \"predict,\" \"project,\" \"should,\" \"would\" and similar expressions\nmay identify forward-looking statements, but the absence of these words does\nnot mean that a statement is not forward-looking. The forward-looking\nstatements contained in this press release are based on certain assumptions\nand analyses made by the management of the Company in light of their\nrespective experience and perception of historical trends, current conditions,\nand expected future developments and their potential effects on the Company as\nwell as other factors they believe are appropriate in the circumstances. There\ncan be no assurance that future developments affecting the Company will be\nthose anticipated. These forward-looking statements involve a number of risks,\nuncertainties (some of which are beyond the control of the parties), or other\nassumptions that may cause actual results or performance to be materially\ndifferent from those expressed or implied by these forward-looking statements,\nincluding the demand for the Company's products, global supply chains and\neconomic activity in general and other risks and uncertainties identified in\nthe Company's filings with the SEC. Should one or more of these risks or\nuncertainties materialize or should any of the assumptions being made prove\nincorrect, actual results may vary in material respects from those projected\nin these forward-looking statements. We undertake no obligation to update or\nrevise any forward-looking statements, whether as a result of new information,\nfuture events, or otherwise, except as may be required under applicable\nsecurities laws.\n\n PRECISION OPTICS CORPORATION, INC. Balance Sheets at June 30, 2026 and 2025 \n 2026 2025 \n ASSETS \n Current Assets: \n Cash and cash equivalents $ 9,841,142 $ 1,773,735 \n Accounts receivable, net of allowance for credit losses of $108,220 at June 30, 2026 and $80,192 at June 30, 2025 5,944,412 4,336,730 \n Inventories, net 3,829,414 3,562,112 \n Prepaid expenses 494,488 385,390 \n Total current assets 20,109,456 10,057,967 \n \n Fixed Assets: \n Machinery and equipment 3,410,813 3,385,958 \n Leasehold improvements 1,226,171 871,356 \n Furniture and fixtures 645,046 538,428 \n 5,282,030 4,795,742 \n Less—Accumulated depreciation and amortization 4,394,317 4,261,950 \n Net fixed assets 887,713 533,792 \n \n Operating lease right-of-use asset 2,300,866 141,825 \n Patents, net 212,889 232,493 \n Goodwill 8,824,210 8,824,210 \n Total other assets 11,337,965 9,198,528 \n TOTAL ASSETS $ 32,335,134 $ 19,790,287 \n \n LIABILITIES AND STOCKHOLDERS’ EQUITY \n Current Liabilities: \n Current portion of capital lease obligation $ – $ 27,368 \n Current maturities of long-term debt 577,898 577,898 \n Accounts payable 3,582,674 2,909,100 \n Customer advances 2,498,501 1,821,929 \n Accrued compensation and other 1,843,368 764,004 \n Operating lease liability 325,500 50,995 \n Total current liabilities 8,827,941 6,151,294 \n \n Long-term debt, net of current maturities 711,305 1,289,205 \n Operating lease liability, net of current portion 2,446,576 90,954 \n Total liabilities 11,985,822 7,531,453 \n Stockholders’ Equity: \n Common stock, $0.01 par value: 50,000,000 shares authorized; issued and outstanding – 10,972,792 shares at June 30, 2026 and 7,714,701 shares at June 30, 2025 109,728 77,147 \n Additional paid-in capital 80,840,105 69,152,317 \n Accumulated deficit (60,600,521 ) (56,970,630 ) \n Total stockholders’ equity 20,349,312 12,258,834 \n \n TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 32,335,134 $ 19,790,287 \n\n\n\n PRECISION OPTICS CORPORATION, INC. Statements of Operations for the Years Ended June 30, 2026 and 2025 \n 2026 2025 \n \n Revenues $ 31,531,765 $ 19,091,269 \n Cost of goods sold 26,100,545 15,686,836 \n \n Gross profit 5,431,220 3,404,433 \n \n Research and development expenses, net 1,033,156 1,157,963 \n Selling, general and administrative expenses 7,906,672 7,797,761 \n Total operating expenses 8,939,828 8,955,724 \n \n Operating loss (3,508,608 ) (5,551,291 ) \n \n Other expense \n Interest expense (148,129 ) (227,019 ) \n Interest income 31,804 - \n \n Loss before provision for income taxes (3,624,933 ) (5,778,310 ) \n \n Provision for income taxes 4,958 1,936 \n \n Net loss $ (3,629,891 ) $ (5,780,246 ) \n \n Loss per share: \n Basic and fully diluted $ (0.43 ) $ (0.85 ) \n \n Weighted average common shares outstanding: \n Basic and fully diluted 8,530,599 6,790,466 \n\n\n\n PRECISION OPTICS CORPORATION, INC. Statements of Stockholders’ Equity for the Years Ended June 30, 2026 and 2025 \n Number of Shares Common Stock Additional Paid-in Capital Accumulated Deficit Total Stockholders’ Equity \n \n Balance, June 30, 2024 6,073,939 $ 60,739 $ 61,197,433 $ (51,190,384 ) $ 10,067,788 \n Issuance of common stock in a registered direct offering 1,538,368 15,384 6,254,752 – 6,270,136 \n Proceeds from exercise of stock option 71,979 721 88,329 – 89,050 \n Issuance of common stock for consulting services and employees 30,415 303 151,395 – 151,698 \n Stock-based compensation – – 1,460,408 – 1,460,408 \n Net loss – – – (5,780,246 ) (5,780,246 ) \n Balance, June 30, 2025 7,714,701 $ 77,147 $ 69,152,317 $ (56,970,630 ) $ 12,258,834 \n \n Issuance of common stock in public offering 3,194,444 31,944 10,598,734 – 10,630,678 \n Proceeds from exercise of stock option 40,294 404 39,595 – 39,999 \n Issuance of common stock for employee services 23,353 233 100,267 – 100,500 \n Stock-based compensation – – 949,192 – 949,192 \n Net loss – – – (3,629,891 ) (3,629,891 ) \n Balance, June 30, 2026 10,972,792 $ 109,728 $ 80,840,105 $ (60,600,521 ) $ 20,349,312 \n\n\n\n PRECISION OPTICS CORPORATION, INC. Statements of Cash Flows For the Years Ended June 30, 2026 and 2025 \n 2026 2025 \n Cash Flows from Operating Activities: \n Net loss $ (3,629,891 ) $ (5,780,246 ) \n Adjustments to reconcile net loss to net cash (used in) provided by operating activities- \n Depreciation and amortization 279,277 212,439 \n Stock-based compensation expense 1,139,692 1,612,106 \n Non-cash legal expense – 34,881 \n Non-cash interest expense 18,433 11,563 \n Non-cash operating lease expense 252,336 124 \n Loss on disposal of fixed assets 34,506 – \n Changes in operating assets and liabilities: \n Accounts receivable, net (1,607,682 ) (791,239 ) \n Inventories (267,302 ) (694,012 ) \n Prepaid expenses (109,098 ) (86,026 ) \n Accounts payable 673,574 1,511,787 \n Contract liabilities 676,572 649,579 \n Accrued compensation and other 989,364 (76,658 ) \n Net cash used in operating activities (1,550,219 ) (3,395,702 ) \n \n Cash Flows from Investing Activities: \n Additional patent costs (5,564 ) (6,264 ) \n Proceeds from sale of fixed assets 3,000 – \n Purchases of property and equipment (426,786 ) (227,209 ) \n Net cash used in investing activities (429,350 ) (233,473 ) \n \n Cash Flows from Financing Activities: \n Payment of capital lease obligations (27,368 ) (41,114 ) \n Principal payments of long-term debt (596,333 ) (280,440 ) \n Payment of debt issuance costs – (40,000 ) \n Repayments on line of credit – (1,000,000 ) \n Gross proceeds from registered direct offerings of common stock – 6,270,136 \n Proceeds from public offering of common stock, net 10,630,678 – \n Gross proceeds from exercise of stock options 39,999 89,050 \n Net cash provided by financing activities 10,046,976 4,997,632 \n \n Net increase in cash and cash equivalents 8,067,407 1,368,457 \n Cash and cash equivalents, beginning of year 1,773,735 405,278 \n \n Cash and cash equivalents, end of year $ 9,841,142 $ 1,773,735 \n \n Supplemental disclosure of cash flow information: \n Cash paid during the year for income taxes $ 2,600 $ 1,936 \n Cash paid during the year for interest $ 129,696 $ 216,456 \n Leasehold improvements financed by landlord $ 218,750 $ – \n Issuance of common stock for consulting and employee services $ 100,500 $ 151,698 \n Stock based compensation for employee services included in accrued compensation and other $ 90,000 $ – \n Operating right-of-use assets obtained in exchange for operating lease liabilities $ 2,632,584 $ 133,650 \n\n\n\n PRECISION OPTICS CORPORATION, INC. \n RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES \n ADJUSTED EBITDA \n \n Three Months Ended Year Ended \n June 30 June \n 30 \n 2026 2025 2026 2025 \n Net Loss (GAAP) $ (103,787 ) $ (1,402,555 ) $ (3,629,891 ) $ (5,780,246 ) \n \n Stock based compensation 397,193 439,873 1,139,692 1,612,106 \n \n Depreciation and amortization 64,329 59,226 279,277 212,439 \n \n Income Taxes (3,744 ) 1,936 4,958 1,936 \n \n Interest Expense 32,775 44,577 148,129 227,019 \n \n Interest Income (31,804 ) - (31,804 ) - \n \n Adjusted EBITDA (non-GAAP) $ 354,962 $ (856,943 ) $ (2,089,639 ) $ (3,726,746 ) \n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/6d86ce33-7e41-41e5-90b0-1c74cd89785e)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX5YLbKk-20260928","title":"Precision Optics Reports Fourth Quarter and Fiscal Year 2026 Financial Results","author":"Globe Newswire","ticker":"POCI","created":"2026-09-28T20:30:00.481Z","tickers":["POCI"],"exchange":"NASDAQ","article_body":"LITTLETON, Mass., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Precision Optics\nCorporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of\nadvanced optical instruments for the medical and defense/aerospace industries,\ntoday announced financial results for its fourth quarter and fiscal year ended\nJune 30, 2026.\n\nQ4 2026 Financial Highlights (3 Months Ended June 30, 2026)\n* Revenue was $8.8 million, a quarterly record, compared to $6.2 million in\nthe same quarter of the previous fiscal year, representing growth of\napproximately 42%, and compared to $8.7 million in the most recent sequential\nquarter.\n* Production revenue was $8.0 million, a quarterly record, compared to $5.1\nmillion in the same quarter of the previous fiscal year, representing growth\nof approximately 57%, and compared to $7.6 million in the most recent\nsequential quarter.\n* Gross margin was 25.3% compared to 13.0% in the same quarter of the previous\nfiscal year and compared to 23.6% in the most recent sequential quarter.\n* Net loss for the quarter was $(0.1) million, compared to a net loss of\n$(1.4) million in the same quarter of the previous fiscal year and a net loss\nof $(0.1) million in the most recent sequential quarter.\n* Adjusted EBITDA was $0.4 million for the quarter compared to $(0.9) million\nin the same quarter of the previous fiscal year and $0.3 million in the most\nrecent sequential quarter.\nFY 2026 Financial Highlights (Year Ended June 30, 2026)\n* Revenue was $31.5 million, a fiscal year record, compared to $19.1 million\nin the previous fiscal year, representing growth of approximately 65%.\n* Production revenue doubled to $28.1 million compared to $14.2 million in the\nprevious fiscal year.\n* Gross margin was 17.2% compared to 17.8% in the previous fiscal year.\n* Net loss for the fiscal year declined to $(3.6) million, or $(0.43) per\nshare, from $(5.8) million, or $(0.85) per share, in the previous fiscal year.\n* Adjusted EBITDA was $(2.1) million for the fiscal year compared to $(3.7)\nmillion in the previous fiscal year, an improvement of approximately $1.6\nmillion.\n* Cash and cash equivalents were $9.8 million at June 30, 2026, compared to\n$1.8 million at June 30, 2025.\nRecent Additional Highlights\n* Achieved record quarterly revenue from the Company’s existing top-tier\naerospace customer and continued strong production of its single-use\ncystoscopy surgery system.\n* Continued ramping production under the previously announced $3.5 million\nfollow-on order for the single-use ophthalmic program.\n* Received a $1.3 million follow-on production order from a large defense\ncompany.\n* Recently announced an initial engineering order from a U.S. space technology\ncompany.\n* Continued strengthening the Company’s leadership team with the appointment\nof Peter Thier as Senior Vice President of Sales and Marketing.\nFY 2027 Financial Guidance (Year Ending June 30, 2027)\n* The Company expects fiscal year 2027 revenue to be in the range of $30\nmillion to $33 million, similar to fiscal year 2026. The outlook reflects a\npause in demand from the Company’s existing satellite customer with growth\nin single-use medical device programs, renewed defense production, additional\nprograms transitioning into production and new engineering engagements\nexpecting to partly offset this reduction. The Company expects a stronger\nsecond half of the year as orders are expected to resume from the existing\nsatellite customer.\n* The Company expects fiscal year 2027 Adjusted EBITDA to be in a range of\n$(1.2) million to $(1.7) million.\n“Fiscal 2026 was a year of transformation for Precision Optics, and our\nfourth-quarter results demonstrate the progress we have made. We delivered\nrecord quarterly revenue, and a second consecutive quarter of positive\nAdjusted EBITDA, closing a year in which revenue grew 65%,” said Joe Forkey,\nCEO of Precision Optics. “Our fiscal 2027 revenue guidance is significantly\nimpacted by the temporary pause in production with our existing satellite\ncustomer. As that customer resumes orders and we execute on growing existing\nand new customers, we anticipate returning to record quarterly revenue levels\nin the second half of the fiscal year. We believe there is a significant\nmarket opportunity, and we will continue to invest in capabilities, capacity\nand market penetration.”\n\n“Rebuilding our product development pipeline is a priority led by our new\nSVP of Sales and Marketing. We received an initial engineering order from a\nsecond satellite customer. Although it is still early, we see the potential to\nbuild another meaningful, long-term production relationship.”\n\nThe following table summarizes the fourth quarter and fiscal year results for\nthe periods ended June 30, 2026 and 2025. Fourth-quarter results are\nunaudited.\n\n Three Months Ended June 30 2026 Three Months Ended June 30 2025 Year Ended June 30 2026 Year Ended June 30 2025 \n Revenues $ 8,774,474 $ 6,181,342 $ 31,531,765 $ 19,091,269 \n Cost of goods sold 6,550,806 5,382,155 26,100,545 15,686,836 \n Gross profit 2,223,668 799,187 5,431,220 3,404,433 \n Total operating expenses 2,330,228 2,155,229 8,939,828 8,955,724 \n Operating income (loss) (106,560 ) (1,356,042 ) (3,508,608 ) (5,551,291 ) \n Interest income (expense), net (971) (44,577) (116,325) (227,019) \n Income (loss) before income taxes (107,531) (1,400,619) (3,624,933) (5,778,310) \n Income tax expense (benefit) (3,744) 1,936 4,958 1,936 \n Net Loss $ (103,787 ) $ (1,402,555 ) $ (3,629,891 ) $ (5,780,246 ) \n Earnings (loss) per share, basic $(0.01) $(0.18) $(0.43) $(0.85) \n Earnings (loss) per share, diluted $(0.01) $(0.18) $(0.43) $(0.85) \n Weighted average shares, basic 10,943,843 7,690,084 8,530,599 6,790,466 \n Weighted average shares, diluted 10,943,843 7,690,084 8,530,599 6,790,466 \n\nConference Call Details\n\nDate and Time: Monday, September 28, 2026, at 5:00 p.m. ET.\n\nCall-in Information: Interested parties can access the conference call by\ndialing (844) 735-3662 or (412) 317-5705.\n\nLive Webcast Information: Interested parties can access the conference call\nvia a live webcast, which will be available at\nhttps://app.webinar.net/0E4e7l07PjV.\n\nReplay: A teleconference replay of the call will be available for seven days\nat (855) 669-9658 or (412) 317-0088, replay access code 7128172. A webcast\nreplay will be available at https://app.webinar.net/0E4e7l07PjV.\n\nAbout Precision Optics Corporation\n\nFounded in 1982, Precision Optics is a vertically integrated optics company\nfocused on leveraging its proprietary micro-optics, multi-channel and\nultra-high precision imaging and digital imaging technologies across the\nmedical device, defense/aerospace and satellite communications markets.\nThrough its Systems Manufacturing, Engineering, Ross Optical and Micro-Optics\nLab operations, the Company provides services from new product concept and\ndesign through volume production. Its in-house optical, mechanical, electrical\nand systems engineering, prototyping, regulatory support, fabrication,\nassembly and manufacturing capabilities enable it to develop next-generation\nsolutions for demanding customer requirements. In medical devices, Precision\nOptics supports minimally invasive and robotic surgery with micro-endoscopes,\nsingle-use and reusable endoscopes, digital imaging and related optical\nassemblies. In defense/aerospace and satellite communications, the Company\napplies its micro-optics and opto-mechanical expertise to applications\nrequiring high quality and optimized size, weight and power. Ross Optical\ncomplements these capabilities through global sourcing, inspection and\nproduction of custom and catalog optics. For more information, please visit\nwww.poci.com.\n\nNon-GAAP Financial Measures\n\nPrecision Optics has provided in this press release financial information that\nhas not been prepared in accordance with accounting principles generally\naccepted in the United States of America (“non-GAAP”). The non-GAAP\nfinancial measure is Adjusted EBITDA (earnings before interest, taxes,\ndepreciation and amortization). In addition to these items, Adjusted EBITDA\nexcludes from Net Income (Loss) the effect of stock-based compensation,\ninterest expense and interest income, depreciation and amortization and income\ntaxes..\n\nThis non-GAAP financial measure assists Precision Optics management in\ncomparing its operating performance over time because certain items may\nobscure the underlying business trends and make comparisons of long-term\nperformance difficult, as they are of a nature and/or size that occur with\ninconsistent frequency or relate to discrete acquisition or restructuring\nplans that are fundamentally different from the ongoing productivity of the\nCompany. Precision Optics management also believes that presenting this\nmeasure allows investors to view its performance using the same measures that\nthe Company uses in evaluating its financial and business performance and\ntrends.\n\nNon-GAAP financial measures should not be considered in isolation from, or as\na substitute for, financial information calculated in accordance with GAAP.\nInvestors are encouraged to review the reconciliation of non-GAAP measures to\ntheir most directly comparable GAAP financial measures. A reconciliation of\nthe non-GAAP financial measure presented above to GAAP results has been\nprovided in the financial tables included with this press release.\n\nPrecision Optics is unable to provide a reconciliation of forward-looking\nAdjusted EBITDA guidance to net income (loss), the most directly comparable\nGAAP financial measure, without unreasonable efforts because of the inherent\ndifficulty in forecasting and quantifying certain amounts that are necessary\nfor such reconciliation, including stock-based compensation expense, which may\nvary significantly based on stock price and other factors outside the\nCompany’s control. The unavailable information could have a significant\neffect on the Company’s GAAP financial results.\n\nAbout Forward-Looking Statements\n\nThis press release contains forward-looking statements within the meaning of\nU.S. federal securities laws including statements concerning our fiscal year\n2027 revenue and Adjusted EBITDA guidance, our expectations regarding customer\ndemand and order resumption, and our anticipated return to record revenue\nlevels. Any statements contained herein that are not statements of historical\nfact may be deemed to be forward-looking statements. In addition, any\nstatements that refer to projections, forecasts, or other characterizations of\nfuture events or circumstances, including any underlying assumptions, are\nforward-looking statements. The words \"anticipate,\" \"believe,\" \"continue,\"\n\"could,\" \"estimate,\" \"expect,\" \"intends,\" \"may,\" \"might,\" \"plan,\" \"possible,\"\n\"potential,\" \"predict,\" \"project,\" \"should,\" \"would\" and similar expressions\nmay identify forward-looking statements, but the absence of these words does\nnot mean that a statement is not forward-looking. The forward-looking\nstatements contained in this press release are based on certain assumptions\nand analyses made by the management of the Company in light of their\nrespective experience and perception of historical trends, current conditions,\nand expected future developments and their potential effects on the Company as\nwell as other factors they believe are appropriate in the circumstances. There\ncan be no assurance that future developments affecting the Company will be\nthose anticipated. These forward-looking statements involve a number of risks,\nuncertainties (some of which are beyond the control of the parties), or other\nassumptions that may cause actual results or performance to be materially\ndifferent from those expressed or implied by these forward-looking statements,\nincluding the demand for the Company's products, global supply chains and\neconomic activity in general and other risks and uncertainties identified in\nthe Company's filings with the SEC. Should one or more of these risks or\nuncertainties materialize or should any of the assumptions being made prove\nincorrect, actual results may vary in material respects from those projected\nin these forward-looking statements. We undertake no obligation to update or\nrevise any forward-looking statements, whether as a result of new information,\nfuture events, or otherwise, except as may be required under applicable\nsecurities laws.\n\n PRECISION OPTICS CORPORATION, INC. Balance Sheets at June 30, 2026 and 2025 \n 2026 2025 \n ASSETS \n Current Assets: \n Cash and cash equivalents $ 9,841,142 $ 1,773,735 \n Accounts receivable, net of allowance for credit losses of $108,220 at June 30, 2026 and $80,192 at June 30, 2025 5,944,412 4,336,730 \n Inventories, net 3,829,414 3,562,112 \n Prepaid expenses 494,488 385,390 \n Total current assets 20,109,456 10,057,967 \n \n Fixed Assets: \n Machinery and equipment 3,410,813 3,385,958 \n Leasehold improvements 1,226,171 871,356 \n Furniture and fixtures 645,046 538,428 \n 5,282,030 4,795,742 \n Less—Accumulated depreciation and amortization 4,394,317 4,261,950 \n Net fixed assets 887,713 533,792 \n \n Operating lease right-of-use asset 2,300,866 141,825 \n Patents, net 212,889 232,493 \n Goodwill 8,824,210 8,824,210 \n Total other assets 11,337,965 9,198,528 \n TOTAL ASSETS $ 32,335,134 $ 19,790,287 \n \n LIABILITIES AND STOCKHOLDERS’ EQUITY \n Current Liabilities: \n Current portion of capital lease obligation $ – $ 27,368 \n Current maturities of long-term debt 577,898 577,898 \n Accounts payable 3,582,674 2,909,100 \n Customer advances 2,498,501 1,821,929 \n Accrued compensation and other 1,843,368 764,004 \n Operating lease liability 325,500 50,995 \n Total current liabilities 8,827,941 6,151,294 \n \n Long-term debt, net of current maturities 711,305 1,289,205 \n Operating lease liability, net of current portion 2,446,576 90,954 \n Total liabilities 11,985,822 7,531,453 \n Stockholders’ Equity: \n Common stock, $0.01 par value: 50,000,000 shares authorized; issued and outstanding – 10,972,792 shares at June 30, 2026 and 7,714,701 shares at June 30, 2025 109,728 77,147 \n Additional paid-in capital 80,840,105 69,152,317 \n Accumulated deficit (60,600,521 ) (56,970,630 ) \n Total stockholders’ equity 20,349,312 12,258,834 \n \n TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 32,335,134 $ 19,790,287 \n\n\n\n PRECISION OPTICS CORPORATION, INC. Statements of Operations for the Years Ended June 30, 2026 and 2025 \n 2026 2025 \n \n Revenues $ 31,531,765 $ 19,091,269 \n Cost of goods sold 26,100,545 15,686,836 \n \n Gross profit 5,431,220 3,404,433 \n \n Research and development expenses, net 1,033,156 1,157,963 \n Selling, general and administrative expenses 7,906,672 7,797,761 \n Total operating expenses 8,939,828 8,955,724 \n \n Operating loss (3,508,608 ) (5,551,291 ) \n \n Other expense \n Interest expense (148,129 ) (227,019 ) \n Interest income 31,804 - \n \n Loss before provision for income taxes (3,624,933 ) (5,778,310 ) \n \n Provision for income taxes 4,958 1,936 \n \n Net loss $ (3,629,891 ) $ (5,780,246 ) \n \n Loss per share: \n Basic and fully diluted $ (0.43 ) $ (0.85 ) \n \n Weighted average common shares outstanding: \n Basic and fully diluted 8,530,599 6,790,466 \n\n\n\n PRECISION OPTICS CORPORATION, INC. Statements of Stockholders’ Equity for the Years Ended June 30, 2026 and 2025 \n Number of Shares Common Stock Additional Paid-in Capital Accumulated Deficit Total Stockholders’ Equity \n \n Balance, June 30, 2024 6,073,939 $ 60,739 $ 61,197,433 $ (51,190,384 ) $ 10,067,788 \n Issuance of common stock in a registered direct offering 1,538,368 15,384 6,254,752 – 6,270,136 \n Proceeds from exercise of stock option 71,979 721 88,329 – 89,050 \n Issuance of common stock for consulting services and employees 30,415 303 151,395 – 151,698 \n Stock-based compensation – – 1,460,408 – 1,460,408 \n Net loss – – – (5,780,246 ) (5,780,246 ) \n Balance, June 30, 2025 7,714,701 $ 77,147 $ 69,152,317 $ (56,970,630 ) $ 12,258,834 \n \n Issuance of common stock in public offering 3,194,444 31,944 10,598,734 – 10,630,678 \n Proceeds from exercise of stock option 40,294 404 39,595 – 39,999 \n Issuance of common stock for employee services 23,353 233 100,267 – 100,500 \n Stock-based compensation – – 949,192 – 949,192 \n Net loss – – – (3,629,891 ) (3,629,891 ) \n Balance, June 30, 2026 10,972,792 $ 109,728 $ 80,840,105 $ (60,600,521 ) $ 20,349,312 \n\n\n\n PRECISION OPTICS CORPORATION, INC. Statements of Cash Flows For the Years Ended June 30, 2026 and 2025 \n 2026 2025 \n Cash Flows from Operating Activities: \n Net loss $ (3,629,891 ) $ (5,780,246 ) \n Adjustments to reconcile net loss to net cash (used in) provided by operating activities- \n Depreciation and amortization 279,277 212,439 \n Stock-based compensation expense 1,139,692 1,612,106 \n Non-cash legal expense – 34,881 \n Non-cash interest expense 18,433 11,563 \n Non-cash operating lease expense 252,336 124 \n Loss on disposal of fixed assets 34,506 – \n Changes in operating assets and liabilities: \n Accounts receivable, net (1,607,682 ) (791,239 ) \n Inventories (267,302 ) (694,012 ) \n Prepaid expenses (109,098 ) (86,026 ) \n Accounts payable 673,574 1,511,787 \n Contract liabilities 676,572 649,579 \n Accrued compensation and other 989,364 (76,658 ) \n Net cash used in operating activities (1,550,219 ) (3,395,702 ) \n \n Cash Flows from Investing Activities: \n Additional patent costs (5,564 ) (6,264 ) \n Proceeds from sale of fixed assets 3,000 – \n Purchases of property and equipment (426,786 ) (227,209 ) \n Net cash used in investing activities (429,350 ) (233,473 ) \n \n Cash Flows from Financing Activities: \n Payment of capital lease obligations (27,368 ) (41,114 ) \n Principal payments of long-term debt (596,333 ) (280,440 ) \n Payment of debt issuance costs – (40,000 ) \n Repayments on line of credit – (1,000,000 ) \n Gross proceeds from registered direct offerings of common stock – 6,270,136 \n Proceeds from public offering of common stock, net 10,630,678 – \n Gross proceeds from exercise of stock options 39,999 89,050 \n Net cash provided by financing activities 10,046,976 4,997,632 \n \n Net increase in cash and cash equivalents 8,067,407 1,368,457 \n Cash and cash equivalents, beginning of year 1,773,735 405,278 \n \n Cash and cash equivalents, end of year $ 9,841,142 $ 1,773,735 \n \n Supplemental disclosure of cash flow information: \n Cash paid during the year for income taxes $ 2,600 $ 1,936 \n Cash paid during the year for interest $ 129,696 $ 216,456 \n Leasehold improvements financed by landlord $ 218,750 $ – \n Issuance of common stock for consulting and employee services $ 100,500 $ 151,698 \n Stock based compensation for employee services included in accrued compensation and other $ 90,000 $ – \n Operating right-of-use assets obtained in exchange for operating lease liabilities $ 2,632,584 $ 133,650 \n\n\n\n PRECISION OPTICS CORPORATION, INC. \n RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES \n ADJUSTED EBITDA \n \n Three Months Ended Year Ended \n June 30 June \n 30 \n 2026 2025 2026 2025 \n Net Loss (GAAP) $ (103,787 ) $ (1,402,555 ) $ (3,629,891 ) $ (5,780,246 ) \n \n Stock based compensation 397,193 439,873 1,139,692 1,612,106 \n \n Depreciation and amortization 64,329 59,226 279,277 212,439 \n \n Income Taxes (3,744 ) 1,936 4,958 1,936 \n \n Interest Expense 32,775 44,577 148,129 227,019 \n \n Interest Income (31,804 ) - (31,804 ) - \n \n Adjusted EBITDA (non-GAAP) $ 354,962 $ (856,943 ) $ (2,089,639 ) $ (3,726,746 ) \n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/6d86ce33-7e41-41e5-90b0-1c74cd89785e)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-09-28T20:30:00.54563442Z","server_sent_at_ms":1790627400545},"received_at":"2026-09-28T20:30:00.783Z","source_url":null},"analysis":{"id":"143354","press_release_id":"154594","analysis_json":{"industry":{"label":"Electronic Equipment, Instruments & Components","sector":"Information Technology"},"redFlags":["FY2027 revenue guided flat vs FY2026 record due to satellite customer demand pause","customer concentration risk: single satellite customer materially drives guidance","share count rose ~42% YoY (7.7M to 11.0M shares) after FY2026 equity offering","FY2027 Adjusted EBITDA still expected negative"],"eventType":"earnings","narrative":"Precision Optics closed fiscal 2026 with record revenue of $31.5 million, up 65% year-over-year, and a record Q4 of $8.8 million (+42% YoY) with gross margin expanding to 25.3%.\n\nThe net loss narrowed to $3.6 million ($(0.43)/share) from $5.8 million, Q4 Adjusted EBITDA turned positive at $0.4 million, and cash ended the year at $9.8 million versus $1.8 million a year ago after a $10.6 million net public offering.\n\nHowever, FY2027 guidance of $30-33 million implies flat revenue, reflecting a pause in demand from the existing satellite customer, with Adjusted EBITDA guided to $(1.2)M-$(1.7)M.\n\nManagement expects orders from the satellite customer to resume and a return to record quarterly revenue in the second half of fiscal 2027, supported by medical device programs and defense production.","sentiment":"mixed","agentHooks":{"shouldPost":true,"suggestedAngle":"Record FY26 with 65% growth, but flat FY27 guide on satellite customer pause -- watch H2 order resumption."},"keyFigures":{"revenue":31531765,"guidance":"FY2027 revenue $30M-$33M (similar to FY2026); Adjusted EBITDA $(1.2)M to $(1.7)M","revenueYoy":"65%","customDimensions":{"q4_revenue":8774474,"q4_revenue_yoy":"42%","q4_gross_margin":"25.3%","fy26_gross_margin":"17.2%","q4_adjusted_ebitda":354962,"cash_and_equivalents":9841142,"production_revenue_fy26":28100000}},"quotedText":"Our fiscal 2027 revenue guidance is significantly impacted by the temporary pause in production with our existing satellite customer.","namedEntities":{"people":[{"name":"Joe Forkey","role":"CEO"},{"name":"Peter Thier","role":"Senior Vice President of Sales and Marketing"}],"products":["single-use cystoscopy surgery system","single-use ophthalmic program","micro-endoscopes"],"companies":[{"name":"Precision Optics Corporation, Inc.","ticker":"POCI"}],"dollarAmounts":[{"amount":"$8.8 million","context":"Q4 FY2026 revenue (quarterly record)"},{"amount":"$31.5 million","context":"FY2026 revenue (fiscal year record)"},{"amount":"$3.5 million","context":"follow-on order for single-use ophthalmic program"},{"amount":"$1.3 million","context":"follow-on production order from a large defense company"},{"amount":"$9.8 million","context":"cash and cash equivalents at June 30, 2026"},{"amount":"$30 million to $33 million","context":"FY2027 revenue guidance"},{"amount":"$(1.2) million to $(1.7) million","context":"FY2027 Adjusted EBITDA guidance"}]},"materialImpact":{"score":4,"reasoning":"Record Q4 revenue (+42% YoY) and near-breakeven net loss, but FY2027 guidance of $30-33M implies flat growth due to a pause in demand from the satellite customer -- a material forward-looking headwind."},"tickerRelevance":{"others":[],"primary":"POCI"},"globalImportance":25,"audienceRelevance":20,"eventTypeSecondary":["guidance_update"],"importanceComponents":{"tickerTier":"micro-cap","eventGravity":"earnings-with-guidance-cut-to-flat","retailFavoriteBoost":false}},"event_type":"earnings","event_type_secondary":["guidance_update"],"sentiment":"mixed","material_impact_score":4,"narrative":"Precision Optics closed fiscal 2026 with record revenue of $31.5 million, up 65% year-over-year, and a record Q4 of $8.8 million (+42% YoY) with gross margin expanding to 25.3%.\n\nThe net loss narrowed to $3.6 million ($(0.43)/share) from $5.8 million, Q4 Adjusted EBITDA turned positive at $0.4 million, and cash ended the year at $9.8 million versus $1.8 million a year ago after a $10.6 million net public offering.\n\nHowever, FY2027 guidance of $30-33 million implies flat revenue, reflecting a pause in demand from the existing satellite customer, with Adjusted EBITDA guided to $(1.2)M-$(1.7)M.\n\nManagement expects orders from the satellite customer to resume and a return to record quarterly revenue in the second half of fiscal 2027, supported by medical device programs and defense production.","key_figures":{"revenue":31531765,"guidance":"FY2027 revenue $30M-$33M (similar to FY2026); Adjusted EBITDA $(1.2)M to $(1.7)M","revenueYoy":"65%","customDimensions":{"q4_revenue":8774474,"q4_revenue_yoy":"42%","q4_gross_margin":"25.3%","fy26_gross_margin":"17.2%","q4_adjusted_ebitda":354962,"cash_and_equivalents":9841142,"production_revenue_fy26":28100000}},"named_entities":{"people":[{"name":"Joe Forkey","role":"CEO"},{"name":"Peter Thier","role":"Senior Vice President of Sales and Marketing"}],"products":["single-use cystoscopy surgery system","single-use ophthalmic program","micro-endoscopes"],"companies":[{"name":"Precision Optics Corporation, Inc.","ticker":"POCI"}],"dollarAmounts":[{"amount":"$8.8 million","context":"Q4 FY2026 revenue (quarterly record)"},{"amount":"$31.5 million","context":"FY2026 revenue (fiscal year record)"},{"amount":"$3.5 million","context":"follow-on order for single-use ophthalmic program"},{"amount":"$1.3 million","context":"follow-on production order from a large defense company"},{"amount":"$9.8 million","context":"cash and cash equivalents at June 30, 2026"},{"amount":"$30 million to $33 million","context":"FY2027 revenue guidance"},{"amount":"$(1.2) million to $(1.7) million","context":"FY2027 Adjusted EBITDA guidance"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-28T20:30:08.601Z","global_importance":25,"audience_relevance":20,"importance_components":{"tickerTier":"micro-cap","eventGravity":"earnings-with-guidance-cut-to-flat","retailFavoriteBoost":false}},"durationMs":7276,"modelName":"glm-5.3-flashx"}}